Cornea/External Disease News

The FDA has accepted the resubmitted new drug application for reproxalap, an investigational treatment for dry eye disease, and assigned a Prescription Drug User Fee Act date, according to a press release from Aldeyra Therapeutics.

NEW YORK — In this Healio Video Perspective from OSN New York, Mitchell A. Jackson, MD, of Jacksoneye in Lake Villa, Illinois, discusses the benefits of corneal tissue addition keratoplasty for patients with keratoconus.

Traumatic iris repair is not uncommon.

BARCELONA, Spain — In this Healio Video Perspective from the European Society of Cataract and Refractive Surgeons meeting, Emilio Torres-Netto, MD, PhD, discusses biomechanical changes produced by the implantation of femto-CAIRS.

BARCELONA, Spain — In this Healio Video Perspective from the European Society of Cataract and Refractive Surgeons meeting, Farhad Hafezi, MD, PhD, gives an update on PTK-assisted customized epi-on cross-linking, or PACE.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Zeba A. Syed, MD, discusses results of a study conducted at Wills Eye Hospital that examined corneal cross-linking complications in more than 900 patients.

Brenting: v. To make bold and audacious deals in the eye care space.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Ranjan P. Malhotra, MD, FACS, discusses how Vevye, a higher-concentration formulation of cyclosporine, is “changing the landscape” in dry eye.

Cross-linking is a unique procedure. As cornea surgeons, we depend on referring doctors to screen for keratoconus, a relatively rare disease.